Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000174

Chairperson & CEO sold 9,500 shares at an average $585.49 ($5,562,190)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-28 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-28 Sale : show line 2 in the form 10b5-1 −821 $583.50 $479,055 333,122 I
2026-10-28 Sale : show line 3 in the form 10b5-1 −2,625 $584.43 $1,534,132 330,497 I
2026-10-28 Sale : show line 4 in the form 10b5-1 −1,902 $585.36 $1,113,352 328,595 I
2026-10-28 Sale : show line 5 in the form 10b5-1 −3,086 $586.37 $1,809,536 325,509 I
2026-10-28 Sale : show line 6 in the form 10b5-1 −986 $587.27 $579,044 324,523 I
2026-10-28 Sale : show line 7 in the form 10b5-1 −80 $588.39 $47,071 324,443 I
Open-market sales · 9,500 sh · avg $585.49 · $5,562,190

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-28 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option −9,500 138,410 I
Loading xslF345X06/primarydocument.xml…